Newsroom
Newsroom
Industry News
Antheia and Olon have announced a continuation of partnership, leveraging Olon’s fermentation infrastructure for the manufacture of Antheia’s early products...
Press Releases
Antheia and Olon established this partnership in 2022 to leverage Olon’s fermentation sites across Italy. Olon has since played a pivotal role as a CDMO...
Press Releases
Company's first full-scale fermentation run reinforces commercial viability for a robust pipeline of Biosynthetic KSMS and APIs...
Industry News
Antheia and Olon have announced a continuation of partnership, leveraging Olon’s fermentation infrastructure for the manufacture of Antheia’s early products...
Press Releases
Antheia and Olon established this partnership in 2022 to leverage Olon’s fermentation sites across Italy. Olon has since played a pivotal role as a CDMO...
Press Releases
Company's first full-scale fermentation run reinforces commercial viability for a robust pipeline of Biosynthetic KSMS and APIs...
Industry News
In a recent Q&A with European Pharmaceutical Manufacturer Antheia CEO and co-founder Dr. Christina Smolke discussed how latency and variability within agricultural supply chains remains...
Industry News
In this Contract Pharma Q&A, we sat down with Kristin Brooks to discuss how our company uses fermentation to produce complex APIs for essential medicines....
Industry News
Senior Scientist Chunshun Li received accolades for his contribution to a recent University of Hawaii Cancer Center discovery. In support of lead researcher Shugeng Cao,...
Industry News
While some synthetic biology companies are using biology to improve our food, clothes, and medicine, others are turning their attention to helping the Earth....
Industry News
Synthetic biology attracted $8.9 billion in venture funding during the first half of 2021, according to synbio stakeholder group SynBioBeta, and launched two successful initial...
Industry News
As a part of my series about “Lessons From Inspirational Women in STEM and Tech”, I had the pleasure of interviewing Christina Smolke......
Press Releases
Today, three leading synthetic biology companies announced the launch of the Synthetic Biology (SynBio) Coalition (www.synbioco.com) to promote investment and support for the American synthetic...
Press Releases
A new paper published today in the journal Nature describes the first successful microbial biosynthesis of the tropane alkaloids hyoscyamine and scopolamine, a class of...
Blog Posts
Since launching Antheia in 2015, we’ve made tremendous strides toward our mission to transform pharmaceutical supply chains for essential medicines. We’ve strengthened our leadership team...
Blog Posts
Antheia was founded in 2015 by Dr. Christina Smolke, CEO and Dr. Kristy Hawkins, CSO and is based in Menlo Park, California. Antheia’s co-founders are...